Reichel Jonathan B, McCormick Jason, Fromm Jonathan R, Elemento Olivier, Cesarman Ethel, Roshal Mikhail
Innovation Laboratory, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center.
Flow-Sorting Core Facility, Weill Cornell Medical College.
J Vis Exp. 2017 Jun 10(124):54399. doi: 10.3791/54399.
The Hodgkin Reed-Sternberg cells of classical Hodgkin lymphoma are sparsely distributed within a background of inflammatory lymphocytes and typically comprise less than 1% of the tumor mass. Material derived from bulk tumor contains tumor content at a concentration insufficient for characterization. Therefore, fluorescence activated cell sorting using eight antibodies, as well as side- and forward-scatter, is described here as a method of rapidly separating and concentrating with high purity thousands of HRS cells from the tumor for subsequent study. At the same time, because standard protocols for exome sequencing typically require 100-1,000 ng of input DNA, which is often too high, even with flow sorting, we also provide an optimized, low-input library construction protocol capable of producing high-quality data from as little as 10 ng of input DNA. This combination is capable of producing next-generation libraries suitable for hybridization capture of whole-exome baits or more focused targeted panels, as desired. Exome sequencing of the HRS cells, when compared against healthy intratumor T or B cells, can identify somatic alterations, including mutations, insertions and deletions, and copy number alterations. These findings elucidate the molecular biology of HRS cells and may reveal avenues for targeted drug treatments.
经典型霍奇金淋巴瘤的霍奇金-里德-斯腾伯格细胞稀疏分布于炎症性淋巴细胞背景中,通常占肿瘤组织的不到1%。来自大块肿瘤的材料所含肿瘤成分的浓度不足以进行特征分析。因此,本文介绍了一种利用8种抗体以及侧向散射和前向散射进行荧光激活细胞分选的方法,可从肿瘤中快速分离并高度纯化富集数千个霍奇金-里德-斯腾伯格细胞以供后续研究。同时,由于外显子组测序的标准方案通常需要100 - 1000 ng的输入DNA,这一量往往过高,即便经过流式分选也是如此,所以我们还提供了一种优化的低输入量文库构建方案,该方案能够从低至10 ng的输入DNA产生高质量数据。这种组合能够根据需要生成适用于全外显子组探针杂交捕获或更具针对性的靶向文库的新一代文库。将霍奇金-里德-斯腾伯格细胞的外显子组测序结果与肿瘤内健康的T细胞或B细胞进行比较,可以识别体细胞改变,包括突变、插入和缺失以及拷贝数改变。这些发现阐明了霍奇金-里德-斯腾伯格细胞的分子生物学特性,并可能揭示靶向药物治疗的途径。